GenSci048

GenSci048 · Changchun GeneScience Pharmaceutical Co., Ltd.

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for GenSci048, covering 2025-08-12 to 2026-04-23. Get the full timeline:

Most recent: Clinical Trial Update: A Study of Efficacy and Safety of GenSci048 in Subjects With Active Uveitis. [Phase 2]